当代孤立性三尖瓣反流的病因、结局及新型风险评分
研究纳入2004年1月至2018年12月超声心动图分级至少中重度孤立性三尖瓣反流的连续患者9045例,中位年龄70.4±15.4岁,女性60.3%。继发性病因占94.8%,以左心疾病(54.4%)、心房功能性(24.3%)和肺部疾病(17.0%)为主;平均随访2.6±3.3年期间死亡3987例(44.0%)。未校正分析中继发性三尖瓣反流生存劣于原发性(HR 1.56;95%CI 1.32-1.85),多变量分析未达统计学显著;作者构建并内部验证了预测1年死亡的风险评分。
要点
- 孤立性显著三尖瓣反流中继发性病因占94.8%,左心疾病为最主要亚类(54.4%)。
- 未校正分析继发性三尖瓣反流生存劣于原发性(HR 1.56;95%CI 1.32-1.85),多变量分析未达统计学显著。
- 作者构建并内部验证了预测孤立性三尖瓣反流患者1年死亡的风险评分。
核心结论
- 继发性三尖瓣反流占孤立性显著三尖瓣反流的95%,未校正分析中生存劣于原发性但校正后未达统计学显著;新型风险评分可对1年死亡风险分层,可能影响这些高危患者的管理决策。
研究设计与样本
- 连续纳入2004年1月至2018年12月超声心动图分级至少中重度孤立性三尖瓣反流的患者9045例(平均年龄70.4±15.4岁,女性60.3%),病因逐一判定为原发性或继发性并分亚类,主要终点为随访期间全因死亡,分析病因与结局关联并构建风险模型。
诊断标准与关键数值
- 三尖瓣反流按超声心动图分级至少中重度纳入;继发性三尖瓣反流中左心疾病4664例(54.4%)、心房功能性2086例(24.3%)、肺部疾病1454例(17.0%);原发性三尖瓣反流中感染性心内膜炎222例(47.2%)、退行性或脱垂86例(18.3%)、人工瓣膜衰败79例(16.8%)。
临床应用与阅片要点
- 作者认为该新型风险评分可对1年死亡风险进行分层,并可能影响这些高危患者的管理决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The authors report etiologies and outcomes and devise a risk model in a large contemporary cohort of patients with isolated tricuspid regurgitation (TR).
BACKGROUND: Isolated TR is a challenging clinical entity with heterogeneous etiology and often poor outcomes, with a paucity of recent research regarding the epidemiology of isolated TR.
METHODS: Consecutive patients with isolated TR graded at least moderate to severe on echocardiography from January 2004 to December 2018 (n = 9,045, mean age 70.4 ± 15.4 years, 60.3% women) were studied. TR etiologies were individually adjudicated as secondary or primary, with subcategories. All-cause death during follow-up was the primary endpoint, with associations between etiology and outcomes analyzed and a risk model created.
RESULTS: Primary and secondary TR etiologies were present in 470 (5.2%) and 8,575 (94.8%) patients, respectively. The main secondary etiologies were left heart disease in 4,664 (54.4%), atrial functional in 2,086 (24.3%), and pulmonary disease in 1,454 (17.0%), and the main primary etiologies were endocarditis in 222 (47.2%), degenerative or prolapse in 86 (18.3%), and prosthetic valve failure in 79 (16.8%). There were 3,987 deaths (44.0%) over a mean follow-up period of 2.6 ± 3.3 years. In unadjusted analyses, patients with secondary TR had worse survival than those with primary TR (HR: 1.56; 95% CI: 1.32-1.85), but this result was not statistically significant in multivariable analysis. The authors devised and internally validated a risk score for predicting 1-year mortality in these patients.
CONCLUSIONS: Secondary TR constituted 95% of isolated significant TR and conferred worse survival than primary TR in unadjusted but not adjusted analyses. The present novel risk score stratifies the risk for 1-year death and may influence decision making for management in these high-risk patients.
引用
- Wang, Akyuz, Mentias, et al. Contemporary Etiologies, Outcomes, and Novel Risk Score for Isolated Tricuspid Regurgitation. JACC Cardiovasc Imaging. 2021. PMID: 34922866. doi:10.1016/j.jcmg.2021.10.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。